The examination of efficacy of small bowel exploration in gastrointestinal graft-versus-host-disease after hematopoietic stem cell transplantation

The examination of efficacy of small bowel exploration in gastrointestinal graft-versus-host-disease after hematopoietic stem cell transplantation - The examination of efficacy of small bowel exploration in GI-GVHD after SCT

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003968

Enrollment

Registered

2010-07-31

Start date

2010-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Graft-versus-Host Disease

Interventions

Case acute GVHD is suspected clinically within 100 days after hematopoietic stem cell transplantation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Case acute GVHD is suspected clinically within 100 days after hematopoietic stem cell transplantation. Case to severity classification stage 3 of gastrointestinalGVHD.

Exclusion criteria

Exclusion criteria: Case of the umbilical cord blood transplant. Case having a serious complication.

Design outcomes

Primary

Measure	Time frame
The histologic GVHD positive rate of the small bowel in case acute GVHD is suspected clinically after hematopoietic stem cell transplantation	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026